RGEN PEER ANALYSIS

Repligen Corporation — metric-by-metric comparison with peers and the industry median

RGENRepligen Corporation

🇺🇸 USA · NASDAQ · Healthcare · Medical Instruments & Supplies

Value it Duel

Overall Profile & Returns

· Medical Instruments & Supplies

Position Within Industry

0 = weak quartile, 100 = strong quartile

RGENIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	RGEN	FPH	RMD	ANN	EL	Ind. Median
P/E	155.96	41.60	20.60●	24.22	34.99	34.99
P/B	3.81	9.15	4.79	1.66●	2.08	2.97
EV/EBITDA	45.89	23.47	14.00	12.55●	14.04	14.66
P/S	10.50	8.33	5.63	1.59●	2.84	2.81

Financial Health
Metric	RGEN	FPH	RMD	ANN	EL	Ind. Median
Current Ratio	9.20●	2.31	3.01	2.36	0.99	2.40
Debt/Equity	32.7%	6.9%●	13.0%	46.2%	37.0%	34.8%
NetDebt/EBITDA	-0.56●	-0.39	-0.38	2.10	1.66	1.44

Profitability
Metric	RGEN	FPH	RMD	ANN	EL	Ind. Median
Net Margin	6.7%	20.0%	27.4%●	6.7%	8.1%	3.9%
ROE	2.5%	23.3%	25.2%●	7.2%	5.8%	2.3%
ROA	1.8%	17.3%	18.6%●	4.2%	3.6%	1.5%
EBITDA Margin	22.6%	34.9%	39.1%●	15.2%	23.0%	13.8%

Growth + Dividend
Metric	RGEN	FPH	RMD	ANN	EL	Ind. Median
Rev. Growth	18.2%●	4.8%	10.5%	11.4%	7.5%	6.4%
NI Growth	—	-11.6%	15.9%	23.8%●	-1.8%	14.0%
Div. Yield	—	1.6%	8.0%●	1.7%	2.3%	1.7%
Payout	—	53.9%	22.4%	53.2%	0.0%	22.4%

Valuation
Metric	RGEN	ATR	AVTR	TFX	BAX	ALGN	Ind. Median
P/E	155.96	21.13●	—	—	—	31.38	34.99
P/B	3.81	3.11	1.26●	1.93	1.92	3.25	2.97
EV/EBITDA	45.89	11.20●	83.38	—	26.15	13.79	14.66
P/S	10.50	2.11	1.08	2.11	1.03●	3.29	2.81

Financial Health
Metric	RGEN	ATR	AVTR	TFX	BAX	ALGN	Ind. Median
Current Ratio	9.20●	1.66	1.76	2.55	1.85	1.39	2.40
Debt/Equity	32.7%	53.6%	68.3%	87.1%	160.3%	2.8%●	34.8%
NetDebt/EBITDA	-0.56	1.41	27.87	-26.86●	10.39	-1.04	1.44

Profitability
Metric	RGEN	ATR	AVTR	TFX	BAX	ALGN	Ind. Median
Net Margin	6.7%	10.0%	-8.4%	-35.9%	-9.7%	10.5%●	3.9%
ROE	2.5%	15.0%●	-9.4%	-28.1%	-16.7%	10.8%	2.3%
ROA	1.8%	8.0%●	-4.6%	-14.5%	-5.3%	6.9%	1.5%
EBITDA Margin	22.6%●	21.6%	1.9%	-3.1%	6.5%	22.2%	13.8%

Growth + Dividend
Metric	RGEN	ATR	AVTR	TFX	BAX	ALGN	Ind. Median
Rev. Growth	18.2%●	8.9%	-2.0%	-6.6%	5.1%	2.9%	6.4%
NI Growth	—	4.4%	—	—	—	5.0%●	14.0%
Div. Yield	—	1.5%	—	1.1%	1.7%●	—	1.7%
Payout	—	31.5%	—	-6.0%	-24.2%	—	22.4%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on RGEN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.